| Dacarbazine studied in …STUDIED_INderived156 of 156show fewer |
|---|
| → studied in | NCT05675410Phase 3 · recruiting A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847359Phase 2 · recruiting Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233347Phase 2 · active not recruiting Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03407144Phase 2 · active not recruiting Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517137Phase 2 · active not recruiting Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745076Phase 2 · recruiting Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551583Phase 2 · recruiting Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05922904Phase 2 · active not recruiting PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07275216Phase 2 · recruiting Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06743126Phase 3 · recruiting SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907488Phase 3 · active not recruiting Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma,Lymphocyte-Rich Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06164275Phase 2 · active not recruiting Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04685616Phase 3 · recruiting Brentuximab Vedotin in Early Stage Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671495Phase 2 · completed Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin · 156 trials list this drug (32 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755804Phase 2 · active not recruiting Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01868451NA · completed Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00600496Phase 1 · completed A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) · 156 trials list this drug (32 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01476410Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Adult Hodgkin Lymphoma,Adult Mixed Cellularity Classic Hodgkin Lymphoma,Adult Nodular Sclerosis Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404945Phase 2 · active not recruiting Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920932Phase 2 · active not recruiting Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377566Phase 2 · recruiting A Study of BV-AVD in People With Bulky Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563245Phase 2/Phase 3 · recruiting Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070392Phase 2 · completed Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma · 156 trials list this drug (32 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01712490Phase 3 · completed A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06346067Phase 3 · active not recruiting A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016819Phase 3 · recruiting Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) · 156 trials list this drug (32 active) | — | — | Soft Tissue Sarcoma,Alveolar Soft Part Sarcoma,Leiomyosarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06831370Phase 4 · recruiting A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033914Phase 1/Phase 2 · active not recruiting A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987332Phase 2/Phase 3 · active not recruiting IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma · 156 trials list this drug (32 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04225390Phase 2 · completed Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067037Phase 2 · active not recruiting Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06835049Phase 2 · recruiting Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE) · 156 trials list this drug (32 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984146Phase 2 · recruiting Nivo40-AVD for Advanced Classic Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02979522Phase 1/Phase 2 · active not recruiting A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07002216Phase 2 · recruiting BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03646123Phase 2 · terminated Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01771107Phase 1/Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | AIDS-Related Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03159897Phase 3 · completed FIL Study on ABVD DD-DI as Upfront Therapy in HL. · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049595Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03331341Phase 1/Phase 2 · completed Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087776Phase 3 · terminated Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269355Phase 2/Phase 3 · terminated A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) · 156 trials list this drug (32 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05008224Phase 2 · completed Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03004833Phase 2 · completed Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04733183Phase 2 · active not recruiting Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma · 156 trials list this drug (32 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023124Phase 2 · completed Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor · 156 trials list this drug (32 active) | — | — | Solitary Fibrous Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712202Phase 2 · active not recruiting Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma,Lymphocyte-Rich Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04638790Phase 3 · recruiting First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) · 156 trials list this drug (32 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277924Phase 1/Phase 2 · completed Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas · 156 trials list this drug (32 active) | — | — | Bone Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01716806Phase 2 · completed A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma,Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02661503Phase 3 · unknown HD21 for Advanced Stages · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678327Phase 3 · completed Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03761095Phase 1 · completed A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS) · 156 trials list this drug (32 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06201507Phase 2 · unknown BV-AVD-R Treatment Children Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181738Phase 2 · completed Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01152788Phase 2 · completed Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003389Phase 3 · completed Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01390584Phase 2 · terminated Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003027Phase 3 · completed Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226249Phase 2 · unknown PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma,Nodular Sclerosis Classical Hodgkin Lymphoma,Lymphocyte-Rich Classical Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01359956Phase 3 · completed Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02292979Phase 2 · completed Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822120Phase 2 · completed S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835145Phase 2 · completed Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery · 156 trials list this drug (32 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721772Phase 3 · completed Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01721746Phase 3 · completed A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037) · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02076646Phase 1/Phase 2 · unknown A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00000626Phase 2 · completed Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00615160Phase 1/Phase 2 · terminated PTK/ZK in Disseminated Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132807Phase 2 · completed Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01763164Phase 3 · completed Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01280565Phase 3 · terminated Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02505269Phase 2 · completed Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498979Phase 1 · completed Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02545075Phase 3 · completed A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01704287Phase 2 · completed Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002561Phase 3 · completed Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416832Phase 2 · completed Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433459Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654732Phase 2 · completed Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200040Phase 2 · unknown A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02190838Phase 2 · terminated Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03527628Phase 2 · unknown OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00864253Phase 3 · completed A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01551459Phase 2 · completed A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma · 156 trials list this drug (32 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01100528Phase 2 · completed Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance · 156 trials list this drug (32 active) | — | — | Uveal Melanoma,Iris Melanoma,Medium/Large Size Posterior Uveal Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01542255Phase 2 · terminated Metronomic Therapy in Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038558Phase 3 · completed Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01569204Phase 2 · completed Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369681Phase 2 · completed Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01692678Phase 3 · completed A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089544Phase 2 · terminated Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall · 156 trials list this drug (32 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01692691Phase 2 · terminated Dacarbazine and Carmustine in Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056679Phase 1 · completed Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01693068Phase 2 · completed Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01227889Phase 3 · completed A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma · 156 trials list this drug (32 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143402Phase 2 · completed Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye · 156 trials list this drug (32 active) | — | — | Uveal Melanoma,Iris Melanoma,Medium/Large Size Posterior Uveal Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00849875Phase 2 · terminated A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma Patients · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091572Phase 3 · completed Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267) · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164007Phase 2 · completed A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01705392Phase 2 · terminated Bevacizumab vs Dacarbazine in Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00802880Phase 2 · completed Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma · 156 trials list this drug (32 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01974752Phase 3 · completed Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT) · 156 trials list this drug (32 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01133977Phase 1/Phase 2 · completed E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01006980Phase 3 · completed A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3) · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00920153Phase 3 · terminated Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01343277Phase 3 · completed A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma · 156 trials list this drug (32 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02797717NA · recruiting Treatment for Classical Hodgkin Lymphoma in Children and Adolescents · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412581Phase 1 · completed Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936221Phase 2 · completed Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028222Phase 2 · completed A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251107Phase 3 · completed Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00526318NA · unknown Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma · 156 trials list this drug (32 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01681212Phase 2 · completed Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110994Phase 2 · completed Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma · 156 trials list this drug (32 active) | — | — | Malignant Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006237Phase 3 · completed S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01060904Phase 1 · completed A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354523Phase 1/Phase 2 · terminated Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma · 156 trials list this drug (32 active) | — | — | Solid Neoplasm,Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324155Phase 3 · completed Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00533702Phase 2 · completed A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004010Phase 2 · completed Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01055522Phase 2 · terminated Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002791Phase 2 · completed Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma · 156 trials list this drug (32 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016263Phase 3 · completed Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070343NA · unknown Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301 · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00796991Phase 1 · completed Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002802Phase 3 · completed Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma · 156 trials list this drug (32 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003421Phase 3 · completed Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041210Phase 3 · unknown Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00395070Phase 3 · completed A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004141Phase 2 · completed Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00246012Phase 1/Phase 2 · completed A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025064Phase 2 · unknown Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410631Phase 3 · unknown Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma · 156 trials list this drug (32 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017225Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma · 156 trials list this drug (32 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416377NA · unknown Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504504Phase 2 · completed Rituximab and ABVD for Hodgkin's Patients · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023738Phase 1/Phase 2 · completed Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma · 156 trials list this drug (32 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072124Phase 3 · completed Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033644Phase 2 · terminated Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus · 156 trials list this drug (32 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404936Phase 2 · completed Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005090Phase 3 · terminated S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease · 156 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002669Phase 2 · completed Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00257205Phase 3 · completed CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002882Phase 3 · completed Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma · 156 trials list this drug (32 active) | — | — | Malignant Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01468740Phase 2 · unknown Prospective Study on HIV-related Hodgkin Lymphoma · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00264953Phase 3 · completed HD11 for Intermediate Stages · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265018Phase 3 · completed HD10 for Early Stages · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496223Phase 1/Phase 2 · terminated A Phase I/II Study of Sunitinib and Dacarbazine · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00327600Phase 1/Phase 2 · completed Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516802Phase 1 · completed A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine · 156 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00308607Phase 2 · completed Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070642Phase 2 · completed CPG 7909 Injection in Melanoma · 156 trials list this drug (32 active) | — | — | Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00779714Phase 3 · unknown Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003647Phase 3 · completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006200Phase 2 · unknown Thalidomide and Dacarbazine for Metastatic Melanoma · 156 trials list this drug (32 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |